Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion type Assertion NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_head.
- NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion description "[Further analysis of haplotype combinations demonstrated that drug-resistant patients tended to have the CGC/CGC, CGC/TGC, CGC/TTT, and TGC/TTT haplotype combinations over the seizure-free patients and controls (all p-values < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_provenance.
- NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion evidence source_evidence_literature NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_provenance.
- NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion SIO_000772 16004559 NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_provenance.
- NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion wasDerivedFrom befree-20150227 NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_provenance.
- NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_assertion wasGeneratedBy ECO_0000203 NP735006.RAl6u4VvyjXC3D1RWTElD65HmnTMcSWrh0NYi5waFSeAw130_provenance.